Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harri Rusanen

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|October 3, 2024
Childhood Developmental Milestones and Risk of Adult Cerebrovascular Disease: The Northern Finland Birth Cohort 1966Milja Kivelä, Ina Rissanen, Eero Kajantie, et al.
Journal of Neurosurgery|June 4, 2008
Impact of ischemic heart disease and atrial fibrillation on survival after spontaneous intracerebral hemorrhageSami Tetri, Liisa Mäntymäki, Seppo Juvela, et al.
Stroke|June 6, 2024
Overweight in Adolescence and Young Adulthood in Association With Adult Cerebrovascular Disease: The NFBC1966 StudyUrsula Mikkola, Ina Rissanen, Milja Kivelä, et al.
Interventional Neurology|November 10, 2017
Internal Carotid Artery and the Proximal M1 Segment Are Optimal Targets for Mechanical ThrombectomyNiko Sillanpää, Sara Protto, Jukka T Saarinen, et al.
Stroke|March 18, 2022
Early Childhood Growth and Risk of Adult Cerebrovascular Disease: The NFBC1966Milja Kivelä, Markus Paananen, Eero Kajantie, et al.
Journal of Neuroimmunology|June 15, 2024
XMEN disease caused by the novel MAGT1 p.(Trp136*) mutation may present with neuropsychiatric symptomsHenry Villenheimo, Virpi Glumoff, Sami Räsänen, et al.
Cell Motility and the Cytoskeleton|September 5, 2002
Cytoskeletal structure of myoblasts with the mitochondrial DNA 3243A-->G mutation and of osteosarcoma cells with respiratory chain deficiencyHarri Rusanen, Johanna Annunen, Heli Ylä-Outinen, et al.
Thrombosis Research|April 19, 2008
Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhageSami Tetri, Johanna Hakala, Seppo Juvela, et al.
Neuroradiology|September 10, 2011
The clot burden score, the Boston Acute Stroke Imaging Scale, the cerebral blood volume ASPECTS, and two novel imaging parameters in the prediction of clinical outcome of ischemic stroke patients receiving intravenous thrombolytic therapyNiko Sillanpaa, Jukka T Saarinen, Harri Rusanen, et al.
Cerebrovascular Diseases Extra|May 9, 2012
CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy PerspectiveNiko Sillanpaa, Jukka T Saarinen, Harri Rusanen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cerebrovascular Diseases (Basel, Switzerland)|October 3, 2024
Childhood Developmental Milestones and Risk of Adult Cerebrovascular Disease: The Northern Finland Birth Cohort 1966Milja Kivelä, Ina Rissanen, Eero Kajantie, et al.
Journal of Neurosurgery|June 4, 2008
Impact of ischemic heart disease and atrial fibrillation on survival after spontaneous intracerebral hemorrhageSami Tetri, Liisa Mäntymäki, Seppo Juvela, et al.
Stroke|June 6, 2024
Overweight in Adolescence and Young Adulthood in Association With Adult Cerebrovascular Disease: The NFBC1966 StudyUrsula Mikkola, Ina Rissanen, Milja Kivelä, et al.
Interventional Neurology|November 10, 2017
Internal Carotid Artery and the Proximal M1 Segment Are Optimal Targets for Mechanical ThrombectomyNiko Sillanpää, Sara Protto, Jukka T Saarinen, et al.
Stroke|March 18, 2022
Early Childhood Growth and Risk of Adult Cerebrovascular Disease: The NFBC1966Milja Kivelä, Markus Paananen, Eero Kajantie, et al.
Journal of Neuroimmunology|June 15, 2024
XMEN disease caused by the novel MAGT1 p.(Trp136*) mutation may present with neuropsychiatric symptomsHenry Villenheimo, Virpi Glumoff, Sami Räsänen, et al.
Cell Motility and the Cytoskeleton|September 5, 2002
Cytoskeletal structure of myoblasts with the mitochondrial DNA 3243A-->G mutation and of osteosarcoma cells with respiratory chain deficiencyHarri Rusanen, Johanna Annunen, Heli Ylä-Outinen, et al.
Thrombosis Research|April 19, 2008
Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhageSami Tetri, Johanna Hakala, Seppo Juvela, et al.
Neuroradiology|September 10, 2011
The clot burden score, the Boston Acute Stroke Imaging Scale, the cerebral blood volume ASPECTS, and two novel imaging parameters in the prediction of clinical outcome of ischemic stroke patients receiving intravenous thrombolytic therapyNiko Sillanpaa, Jukka T Saarinen, Harri Rusanen, et al.
Cerebrovascular Diseases Extra|May 9, 2012
CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy PerspectiveNiko Sillanpaa, Jukka T Saarinen, Harri Rusanen, et al.
Pageof 3